Kleo
Kleo is a biotechnology company that develops and commercializes therapeutics for the treatment of cancer and infectious diseases.
Business Model:
Revenue: $3M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Kleo Information
Kleo was acquired by
Biohaven Pharmaceutical.
The acquisition happend on 2021-01-07.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 150 Munson Street
City: New Haven
State: CT
Zip: 06511
Country: US
Financial Info
Stage:
series b
Raised Last:
$21M
Raised Total:$32M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Kleo is a biotechnology company that develops and commercializes therapeutics for the treatment of cancer and infectious diseases.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2017 | Venture Round | $11M | 11/2018 | Series B | $0 |
Biohaven Pharmaceutical Peptidream Biohaven Pharmaceutical Peptidream |
7/2020 | Grant | $5M |
Bill & Melinda Gates Foundation |
11/2018 | Equity | $21.2M | 2/2020 | Equity | $19.4M | 8/2016 | Series A | $13.5M |
Biohaven Pharmaceutical Holding Company, Ltd |
9/2016 | Series A | 1 | - |
Biohaven Pharmaceutical Biohaven Pharmaceutical |
11/2018 | Series B | 2 | $21M |
Biohaven Pharmaceutical Peptidream Biohaven Pharmaceutical Peptidream |
9/2016 | Series A | 1 | - |
Biohaven Pharmaceutical Biohaven Pharmaceutical |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
